Back to search

Article

Risk factors associated with the acquisition of linezolid-resistant Enterococcus faecalis

2019-09-12

Abstract excerpt

<title>Abstract</title> <p>Background Linezolid is used to treat vancomycin-resistant enterococcal infections. Vancomycin-resistant and -susceptible Enterococcus faecalis can develop resistance to linezolid in clinical settings with high linezolid consumption. Linezolid-resistant E. faecalis (LREF) has emerged as a major nosocomial pathogen in our hospital, in which linezolid use is considerable.Aim To define ris...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
48cc4fc2-7f80-51a5-966d-578494047a99
DOI
10.21203/rs.2.14339/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Risk factors associated with the acquisition of linezolid-resistant Enterococcus faecalisDOI 10.21203/rs.2.14339/v1
Select a neighboring publication to make it the new centre.